SCHEMBL3967896

SCHEMBL3967896

Cc1ccc(S(=O)(=O)C(C)(C)C(=O)Nc2cc(C(C)(C)C)nn2C)c(F)c1.Cc1ccc(S(=O)(=O)C(C)(C)C(=O)Nc2cc(C(C)(C)C)on2)c(F)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 5/20 0.53
CNR1 P21554 3/20 0.53
GAA P10253 1/20 0.46
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
MAPK14 Q16539 5/20 0.40
SMN1; SMN2 Q16637 3/20 0.39
TDP1 Q9NUW8 1/20 0.39
LMNA P02545 2/20 0.39
ALDH1A1 P00352 1/20 0.38
FLT3 P36888 3/20 0.38
CSF1R P07333 2/20 0.38
MAPK13 O15264 1/20 0.37
MAPT P10636 1/20 0.37
MAPK12 P53778 1/20 0.37
MAPK11 Q15759 1/20 0.37
PKM P14618 1/20 0.37
TSHR P16473 1/20 0.37
HTT P42858 1/20 0.37
KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3969040 0.91 CNR2 (0.61) CNR2CNR1GAAFLT3CSF1R
SCHEMBL1464880 0.89 CNR2 (0.61) CNR2CNR1GAANPC1RAB9A
SCHEMBL1464022 0.89 CNR2 (0.64) CNR2MAPK14LMNAMAPK13MAPT
SCHEMBL3963553 0.81 CNR2 (0.50) CNR2CNR1GAAMAPK14LMNA
SCHEMBL1465446 0.81 CNR2 (0.64) CNR2MAPK14LMNAMAPK13MAPT
SCHEMBL1464450 0.80 CNR2 (0.62) CNR2CNR1GAANPC1RAB9A
SCHEMBL1463606 0.80 CNR2 (0.74) CNR2CNR1MAPK14LMNAALDH1A1
SCHEMBL1463932 0.78 CNR2 (0.72) CNR2CNR1GAANPC1RAB9A
SCHEMBL1464468 0.78 CNR2 (0.65) CNR2MAPK14LMNAMAPK13MAPT
SCHEMBL3963607 0.78 CNR2 (0.55) CNR2CNR1GAANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2081905-A2 SULFONYL COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR Boehringer Ingelheim International GmbH (DE) 2009-07-29 EP claimed
WO-2008014199-A2 SULFONYL COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2008-01-31 WO claimed
EP-2081905-A2 SULFONYL COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR Boehringer Ingelheim International GmbH (DE) 2009-07-29 EP disclosed
WO-2008014199-A2 SULFONYL COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2008-01-31 WO disclosed